Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Jadhav, Vikrant M.
- A Comparative Study of Efficacy, Safety and Relapse Rate of Three Drugs; Systemic Ketoconazole, Systemic Itraconazole and Topical Oxiconazole in the Treatment of Pityriasis Versicolor
Abstract Views :338 |
PDF Views:90
Authors
Source
MVP Journal of Medical Sciences, Vol 2, No 2 (2015), Pagination: 76-80Abstract
Aim: The aim of our study was to evaluate the efficacy, safety and relapse rate of systemic Ketoconazole, systemic Itraconazole and topical Oxiconazole in the treatment of pityriasis versicolor. Study design: 94 patients who had pityriasis versicolor were included in the study. The patients were given Ketoconazole, Itraconazole and Oxiconazole randomly and were followed up at the interval of 15 days, 1 month and 3 months for assessement of clinical and mycological cure. Results: In assessment of clinical parameters maximum improvement in scaling, pigmentation and pruritus was seen in Oxiconazole group compared to itraconazole and ketoconazole group. During the study it was observed that rate of clinical cure was maximum in Oxiconazole group (76.67%) as compared to Itraconazole (58.82%) and Ketoconazole group (46.66%). Mycological cure during visit 2 in Oxiconazole group was (83.33%), as compared to (88.2%) Itraconazole group and (88.7%) Ketoconazole group. During visit 3, mycological cure was present in 93.3% cases in Oxiconazole group, 94.1% in Itraconazole group and 93.3% in Ketoconazole group. During visit 4 mycological cure was assessed which showed 88.7% cure rate in Oxiconazole group compared to 88.2% in Itraconazole group and 88.7% in Ketoconazole group. These results suggested presence of relapse in 6.6% cases in both Oxiconazole and Ketoconazole group and 5.9% cases in Itraconazole group. There were no side effects with oxiconazole group while cases treated with ketoconazole and itraconazole had side effects like nausea and urticaria. Conclusion: According to the present study we conclude that topical Oxiconazole therapy was more effective as compared to systemic Itraconazole and Ketoconazole therapy in early improvement of scaling, pigmentation and pruritus secondary to Pityriasis versicolor with no significant side effects.Keywords
Efficacy, Itraconazole, Ketoconazole, Pityriasis Versicolor, Topical Oxiconazole.References
- Morishita N, Sei Y. Microreview of PityriasisVersicolor and Malassezia species. Micopathologica. 2006 Dec; 162(6):373-6.
- Kanwar AJ, Dipankar De. Superficial Fungal Infections. IADVL Textbook of Dermatology. R.G.Valia, Amit R.Valia (Editors). 3rd ed. Vol 1. p. 285-93.
- Giam YC, Rajan VS. Oral ketoconazole-A new treatment for tinea versicolor. Singapore Med J. 1984; 25:157-60.
- Richardson M, Warnock D. Other cutanious fungal infection. Fungal infection diagnosis and management. 3rd ed. Blackwell Publishing; p. 129.
- Jegasothy BV, Pakes GE. Oxiconazolenitrate : pharmacology, efficacy and safety of a new imidazole antifungal agent. ClinTher. 1991; 13:126-41.
- Jain VK, Aggarwal K. Comparative study of ketoconazole and itraconazole in pityriasis versicolor. Indian J Dermatol Venereol Leprol. 1999; 65:267-9.
- Bhogal CS, Singal A, Baruah MC. Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study. J Dermatol. 2001; 28:535-9.
- Gugnani HC. Oxiconazole in treatment of topical dermatomycoses. Current therapeutic research. 54(1):122-5.
- Maytham M, Al-Hilo, Hala K, AL-Obaidi, Ahmed Samir Al- Noaimi, Alwan AI. Therapeutic efficacy of different azole antifungal regimens in treatment of tineaversicolor. International Journal of advanced Biological Research. 2012: 2(4):766-71..
- Mohanty J, Sethi J, Sharma MK. Efficacy of Itraconazole in the treatment of PityriasisVersicolor. Indian Journal Dermatology Venereology Leprology. 2001; 67(5):240-1.
- Silva H, Gibbs D, Arguedas J. A comparison of fluconazole with Ketoconazole, Itraconazole and Clotrimazole in the treatment of patients with Pityriasisversicolor. Current Therapeutic Research. 1998; 59(4):203-14.
- Comparative Study of Efficacy of Topical Minoxidil 5% and Combination of Topical Minoxidil 5%, Topical Azelaic Acid 1.5% and Topical Tretinoin 0.01% on the Basis of Dermoscopic Analysis in Androgenetic Alopecia
Abstract Views :235 |
PDF Views:86
Authors
Source
MVP Journal of Medical Sciences, Vol 2, No 2 (2015), Pagination: 90-99Abstract
Background: Androgenetic alopecia (AGA) more commonly known as male pattern baldness affects up to 50% of men worldwide. Tretinoin prolongs anagen phase and increases percutaneous absorption of minoxidil three fold. Azelaic acid is an inhibitor of 5 alpha reductase and could be an effective agent in the treatment of androgen related pathology of human skin. Aims and Objective: 1) To study the efficacy of topical minoxidil 5% in treatment of androgenetic alopecia. 2) To study the efficacy of combination of topical minoxidil 5%, topical azelaic acid 1.5% and topical tretinoin 0.01% in treatment of androgenetic alopecia. 3) To compare the efficacy of foresaid topical preparation in treatment of androgenetic alopecia Setting: Outpatient department of Dermatology, Venerology Leprology of a tertiary health care centre with an attached medical college. Material and methods: Topical minoxidil 5 % lotion was used in 23 (50%) patients of the present study. Combination of topical minoxidil 5%, azelaic acid 1.5 % and tretinoin 0.01 % lotion was used in 23 (50 %) patients of the present study. Statistical analysis used: Epi info version 7. Results: There was statistically significant increase in hair number and thickness after treatment in both the groups. The comparison of the increase of hair number and thickness was statistically insignificant. Conclusions: Topical Minoxidil 5% is equally effective to combination of topical Minoxidil 5%, azelaic acid 1.5% and tretinoin 0.01% in treatment of androgenetic alopecia.Keywords
Androgenetic Alopecia, Azelaic Acid, Minoxidil, Tretinoin.- Study of Homologous Autoimplantation Therapy for Treatment of Multiple Warts in Patients Attending the Dermatology out Patient Department
Abstract Views :219 |
PDF Views:81
Authors
Source
MVP Journal of Medical Sciences, Vol 2, No 2 (2015), Pagination: 110-117Abstract
Introduction: Warts are benign tumours that commonly involve skin and other epithelial tissues. There is no single treatment modality that is 100% effective. In multiple warts, especially on face, palms, and soles destructive procedure are inappropriate and impractical. Homologous autoimplantation is a simple technique, which helps in inducing cell mediated response, causing clearance of warts. Aims and objectives: To evaluate the effect of homologous autoimplantation therapy in treatment of multiple warts. To study the untoward effects of this treatment. Material and methods: A total of 49 patients of viral warts were included in study. Homologous autoimplantation of wart was done and regular follow up was done to see the result. Results: Out of 49 patients, in 24 patients there was good response, 14 showed moderate response, 5 showed poor response and in 6 patients there was no response. Conclusion: Homologous autoimplantation is an easy, minimally invasive technique which clears multiple, recurrent and recalcitrant warts.Keywords
Homologous Autoimplantation, Warts.References
- Drake LA, Ceilley RI, Cornelison RL, Dobes WL, Dorner W, Goltz RW, et al. Guidelines of care for warts: Human papilloma viruses. J AM AcadDermatol. 1995 Jan; 32(1):98-103.
- Srivastava PK, Bajaj AK. Autowart injection therapy for recalcitrant warts. Indian J Dermatol. 2010 Oct-Dec; 55(4): 367-9.
- Lipke MM. An Armamentarium of Wart Treatments. Clin Med Res. 2006 Dec; 4(4):273-93.
- Sterling JC, Handfield-Jones S, Hudson PM. British Association of Dermatologists. Guidelines for the management of cutaneous warts. Br J Dermatol. 2001 Jan; 144(1):4-11.
- Androphy EJ, Lowy DR. ‘Warts’, in Klaus Wolff, Lowell A. Goldsmith, Amy S. Paller, David J. Leffell. Fitzpatrick’s Dermatology in General Medicine. 7th ed. Vol. 2. United States of America: The McGraw-Hill Companies; 2008. p. 1914-23.
- Shivkumar V, Okade R, Rajkumar V. Autoimplantation therapy for multiple warts. Indian J Dermatolvenerolleprol. 2009 Nov-Dec; 75(6):593-5.
- Viac J, Thivolet J, Hegary MR, Chardonnet Y, Dambuyant C. Comparative study of delyed hypersensitivity skin reaction and antibodies to human papilloma virus. ClinExpimmunol. 1997; 29(2):240-6.
- Nischal KC, et al. A novel modification of autoimplantation therapy for the treatment of multiple recurrent and palmoplantar warts. J Cutanaestsurg. 2012 Jan-Mar; 5(1):26-9.
- Kuykendall-Ivy TD, Johnson SM. Evidence-based review of managementof nongenital cutaneous warts. Cutis. 2003 Mar; 71(3):213-22.
- Viac J, Thivolet J, Chardonnet Y. Specific immunity in patients sufferingfrom recurring warts before and after repetitive intradermal tests withhuman papilloma virus. Br J Dermatol. 1977 Oct; 97(4):365-70.
- Venugopal SS, Murrell DF. Recalcitrant Cutaneous warts treated with recombinant quadrivalent human papilloma virus vaccine (types 6, 11, 16and 18) in a developmentally delayed, 31-year-old white man. ArchDermatol. 2010 May; 146(5):475-7.
- Kreuter A, Waterboer T, Wieland U. Regression of Cutaneous warts ina patient with WILD syndrome following recombinant quadrivalent humanpapilloma virus vaccination. Arch Dermatol. 2010 Oct; 146(10):1196-7.
- Briggaman RA, Wheeler CE Jr. Immunology of human warts. J Am Acad Dermatol. 1979 Oct; 1(4):297-304.